An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom.
Chemical ID:
MESH:C032793
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
3-methyladenine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Arsenic Trioxide affects the reaction [lipopolysaccharide, E coli O55-B5 affects the expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]
ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in increased expression of SQSTM1 protein]; MAP1LC3B protein affects the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of SQSTM1 protein]
3-methyladenine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SQSTM1 mRNA; Arsenic Trioxide promotes the reaction [EGFR protein mutant form binds to SQSTM1 protein]; Arsenic Trioxide promotes the reaction [SQSTM1 protein binds to FLT3 protein mutant form]; Arsenic Trioxide promotes the reaction [SQSTM1 protein results in increased localization of BCR protein mutant form]; Chloroquine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of SQSTM1 protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; SQSTM1 protein affects the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]; SQSTM1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]; SQSTM1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]
